| Literature DB >> 33585201 |
Gloria Taliani1,2,3, Elena Follini4, Lorenzo Guglielmetti1,5,6, Patrizia Bernuzzi4, Alberto Faggi1, Patrizia Ferrante1,7, Elisa Fronti1, Laura Gerna1, Maria Cristina Leoni1, Franco Paolillo1, Giovanna Ratti1, Alessandro Ruggieri1, Caterina Valdatta1, Alessandra Donisi8, Adriano Zangrandi9, Lara Pochintesta4, Carlo Moroni4, Daria Sacchini1, Daniele Vallisa4, Mauro Codeluppi1.
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects humans through the angiotensin converting enzyme-2 (ACE-2) receptor expressed on many cells, including lymphocytes. In Covid-19 patients IL-6 is overexpressed, and hyperactivated plasmacytoid lymphocytes are detected in peripheral blood film. We hypothesize that, due to the unpredictable interaction between the new virus and the B cell lineage of infected patients, a cascade of out of control events can ensue, capable of determining unexpected pathologic disorders involving such lineage. Here we report two cases of autoimmune hemolytic anemia (AIHA) and two cases of B-cell hematological malignancies developed or reactivated during acute SARS-CoV-2 infection. The temporal relationship of the events may suggest a potential causal relationship between SARS-CoV-2 infection and the hematopoietic disorders. We suggest that special attention should be paid to COVID-19 patients with underlining B cell lineage disorders.Entities:
Keywords: B-cell lineage malignancies; COVID-19; acute lymphoblastic leukemia; autoimmune hemolytic anemia; multiple myeloma; reactivation
Year: 2021 PMID: 33585201 PMCID: PMC7874205 DOI: 10.3389/fonc.2020.582901
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244